Pneumocandin D0

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePneumocandin D0
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsNatural product/Extract
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsPneumocystis Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsPneumocystis Infections

Other Information

ATC CodeN/A
Related LinksN/A